Brings total raised to $130M, former PURE Chief Underwriting Officer joins as President of P&C and former Nephila executive joins as CFO. Total insured value grows 10X to $10B.

SAN FRANCISCO, Oct. 15, 2026 — Stand today announced it has raised a $70 million Series C at a $1 billion valuation. The round was led by Saga Ventures with participation from Lowercarbon, Eclipse, Equal Ventures, Inspired Capital, Neotribe, and Jackson Square Ventures, among others. Stand now insures more than $10 billion of property, up from $1 billion a year ago. The company is building toward a single mission: to insure all the world’s resilient property, by making homes safer and thus insurance cheaper.

Disasters are getting bigger and more frequent. A billion-dollar weather disaster now strikes the U.S. every 10 days. For many homeowners, insurance has become expensive, hard to find, and unpredictable. Premiums jump, coverage gets harder to renew, and families are often left scrambling, even when nothing about their home has changed. That’s because insurance is still priced by looking backward at past disasters. Stand believes the answer is physics: simulate how a home will actually perform in a disaster, make it resilient, and insure it with confidence for decades. This means safer homes, cheaper insurance and more durable coverage.

It starts with simulation. The Stand World Model creates a digital representation of every home and simulates how it will perform under fire, wind, and other disasters. It accounts for the home’s construction, its surroundings, and the weather it faces. Instead of waiting decades for history to reveal what works, Stand pulls the future forward. It shows exactly what makes a specific home vulnerable and the most cost-effective ways to protect it.

Stand helps make the home resilient. Stand analyzes a specific home and recommends improvements to increase safety while preserving character. Stand also helps owners do the work: it guides each step, connects them with trusted partners, and confirms completed improvements on their behalf.

Stand insures it for the long run. Resilient homes are less likely to burn in a wildfire, and Stand shares the savings from this reduction in risk with homeowners in the form of discounts of up to 70%. Just as important, they earn stability. Since the properties are resilient to disasters, owners and their brokers can count on highly competitive, stable prices and coverage over time.

“Disasters follow the laws of physics, and insurance should too,” said Dan Preston, co-founder and CEO of Stand. “If your home is resilient, you should be rewarded with a low premium and never have to worry about losing your coverage. We want to insure every resilient property in the world, and help make every property safe.”

Leadership additions

Stand also announced the addition of two senior executives to continue to scale growth.

Drew Saad joins as President of Property & Casualty. He was most recently Chief Underwriting Officer at PURE Insurance, where he led underwriting for one of the country’s leading high-net-worth insurers.

“The companies that reshape a market for decades are the ones that identify a fundamentally better way to understand risk, and Stand has done that for the homes exposed to natural disasters,” said Saad. “With the science already in place, the opportunity now is to build an insurance operation that matches it and scales it to every market that needs it. That is the work I have spent my career preparing for, and it is why I joined Stand.”

Tony Landi joins as Chief Financial Officer. He was most recently Head of Strategic Growth at Nephila, one of the world’s largest fund managers of catastrophe reinsurance. Before that, he was Head of Reinsurance & Capital Management at Openly and Head of Portfolio Management at Everest Re. At Stand, he will lead finance, reinsurance, capital markets, and growth strategy as the company scales.

“What drew me to Stand is the depth of the team, with real experts in physics, underwriting, and product working on the same problem,” said Landi. “My job is to make sure that as Stand grows, the capital is there to support it, from our investors and our reinsurance partners alike. We’ll do that by building diversified, resilient portfolios and matching risk and returns to capital appetite.”

About Stand

Stand protects and insures homes in catastrophe-exposed regions by partnering with homeowners to understand what drives their risk and physically strengthen their properties. Stand underwrites and services policies issued by Concert Specialty Insurance Company (AM Best A-) in California and Stand Insurance Exchange (Demotech A) in Florida, reinsured by AM Best A and A+ reinsurers such as Arch, RenaissanceRe, Hannover, Nephila, and Hiscox. Learn more at standinsurance.com.

Media Contact

[email protected]

SOURCE Stand Insurance

TIME recognizes TBC’s breakthrough in translating discoveries from living neurons into faster and more efficient AI models.

SAN FRANCISCO, Oct. 15, 2026 — The Biological Computing Co. (TBC), an applied biological computing company, today announced that its neuron-derived technology, behind its first AI model, has been named to TIME’s Best Inventions of 2026.

TBC has built a biological discovery platform that translates how living neurons process information into technology that improves AI models running on silicon the world has deployed. The award-winning software adapter is the first commercial product to emerge from this platform, with video generation as its first application.

“The brain is the most efficient computer we know, and we’re learning directly from it to build better AI,” said Alex Ksendzovsky, co-founder and CEO of TBC. “Our first application in AI video generation demonstrates what’s possible when we apply discoveries from living neurons to AI. And the opportunity extends far beyond video. We’re building a discovery platform that can scale these advances across AI models and ultimately change how AI is designed and run.”

Video generation is among the most computationally demanding applications of AI. TBC’s neuron-derived technology makes existing AI video models faster and less expensive to run, using the same silicon and infrastructure customers already have.

To compile its annual Best Inventions list, TIME solicits nominations from its editors and correspondents around the world and through an online application process. Contenders are evaluated on originality, efficacy, ambition and impact.

See the full list at ti.me/best-inventions.

About The Biological Computing Co. (TBC)

The Biological Computing Co. (TBC). is an applied biological computing company that uses living neurons to improve AI models. TBC makes intelligence radically more efficient by learning from biology. Discoveries in real neurons improve AI models that run on silicon the world already owns. Customers get better AI without changing their infrastructure. Headquartered in San Francisco, TBC is a fast-growing team of neuroscientists, biologists, AI researchers and engineers redefining how the world computes.

Media Contact
[email protected]

SOURCE The Biological Computing Co.

Former Appen CEO and Dell Technologies cloud and AI executive joins board to advance PointClickCare’s AI-first healthcare strategy

TORONTO, Oct. 15, 2026 — PointClickCare, a leading health tech company helping providers deliver exceptional care, today announced the appointment of Armughan Ahmad to the company’s board of directors.

Ahmad brings over 25 years of enterprise technology leadership and has built and led multi-billion-dollar businesses through the industry’s major platform shifts, from enterprise data centers to cloud computing to today’s era of artificial intelligence. He previously served as Chief Executive Officer of Appen (ASX: APX), an AI data company serving leading AI labs, hyperscalers, and large enterprises. Prior to Appen, he was President and Managing Partner of Digital at KPMG, where he led the digital business delivering services with software products. Earlier he served as Senior Vice President and General Manager at Dell Technologies, where he oversaw the Hybrid Cloud and High-Performance Computing solutions portfolio, including bringing AI systems to market with NVIDIA.

“We’re thrilled to welcome Armughan to our board of directors. As we continue to advance our vision of an AI-first future for healthcare, his extensive track record of scaling technology businesses and guiding AI strategies through major industry shifts will be invaluable,” said Dave Wessinger, co-founder and chief executive officer at PointClickCare. “Armughan’s deep AI expertise and strategic vision will support our efforts to drive clinical and operational innovation for our customers.”

Today, Ahmad actively advises C-suite executives on leveraging AI to turn services into software and invests in AI-first software start-ups. He currently serves as an independent board director at Flexential, which manages 40 data centers across the U.S., and as a board director of Trillium Health Partners, a leading Ontario hospital system. Ahmad holds honorary Doctor of Laws degrees from McMaster University (DeGroote School of Business) and the University of Waterloo (Faculty of Engineering).

“PointClickCare is at the forefront of healthcare technology, leveraging data and innovation to make a real impact on care delivery and patient outcomes,” said Ahmad. “I am honored to join the board at such a pivotal time in the company’s evolution and look forward to collaborating with the entire leadership team to accelerate our AI strategy and fuel the next phase of growth.”

Ahmad’s appointment further enhances PointClickCare’s board capabilities across technology, SaaS, and AI sectors. Concurrent with this transition, Rob Eberle has concluded his service on the board of directors.

“We extend our sincere gratitude to Rob for his leadership, dedication, and valuable contributions to PointClickCare during his 11+ years on the board,” said Wessinger.

For more information about PointClickCare’s leadership team and board of directors, please visit here.

About PointClickCare

PointClickCare is a leading health tech company with one simple mission: to help providers deliver exceptional care. With the largest long‐term and post‐acute care dataset, we power AI-driven healthcare to deliver intelligent transitions, insightful interventions, and improved financial performance. Enhanced by our marketplace of 500+ integrated partners and trusted by over 30,000 provider organizations and every major U.S. health plan, we’re redefining healthcare, so it doesn’t just survive—it thrives.

Media Contact:
PointClickCare
[email protected]

SOURCE PointClickCare

Annual originations more than quadrupled from 2022 to 2025 and reached $867 million in the first nine months of 2026; company introduces new brand and website

NEW YORK, Oct. 15, 2026 — SBG Funding, a New York City-based small-business financing company, has delivered more than $3 billion in financing to more than 28,000 U.S. small businesses since it was founded in 2017, the company announced today. SBG Funding also introduced a new brand identity, built around the line “Capital That Keeps Up,” and a new website at sbgfunding.com.

The company’s annual originations grew from $7.9 million in its first months of operation in 2017 to $189 million in 2022, $422 million in 2024 and $794 million in 2025. Through September 2026 it originated $867 million, already more than in all of 2025, and it is on pace for $1.15 billion this year. SBG Funding was named to the Inc. 5000 list of America’s fastest-growing private companies for the fifth consecutive year in 2026, ranking No. 778.

The new brand puts the company’s mission up front: fast, flexible and responsible capital for the small-business community. SBG Funding works with established companies that have steady revenue, and owners use its financing for needs such as payroll through a slow season or equipment for a new contract.

“Small businesses don’t schedule their opportunities. A contractor wins a bid on Monday and needs equipment by Friday, or a restaurant’s walk-in cooler fails in the middle of July. Capital That Keeps Up is our promise that the money moves as fast as those owners do, and after more than 64,000 transactions, we know what that takes,” said Jeffrey Sachs, founder and CEO of SBG Funding.

The new website is built around how the company works today. Through one application, a business owner can be matched with revenue-based financing, a term loan, a line of credit, equipment or invoice financing, or SBA financing of up to $10 million, with a dedicated adviser handling the file from application to funding. Applying does not affect the owner’s credit score, and decisions typically come within 24 hours.

“When a customer comes back for more capital, their adviser already knows the business. That’s a big reason the second decision is often faster than the first,” said Adam Block, vice president of sales and operations at SBG Funding.

About SBG Funding

SBG Funding is a New York City-based small-business financing company serving businesses across all 50 U.S. states. Since 2017, it has delivered over $3 billion in financing to more than 28,000 U.S. small businesses. SBG Funding is a direct provider of revenue-based financing and a marketplace offering a broad range of funding solutions through an extensive network of lenders.

SBG Funding is led by Jeffrey Sachs, founder and CEO. Its mission is to provide fast, flexible and responsible capital to the small-business community. Customers have come back for more than 64,000 transactions in total, which the company credits to fast decisions and advisers who understand how small-business cash flow works.

SBG Funding’s products include revenue-based financing, term loans, lines of credit, equipment financing, invoice financing and SBA financing up to $10 million. The company serves small businesses across many industries, with concentrated activity in construction, manufacturing, medical and health care, retail, food and beverage, and trucking and transportation. SBG Funding is a five-time Inc. 5000 honoree and maintains a 4.9-star Trustpilot rating.

To learn more, visit sbgfunding.com.

Media contact: Jay Egger, SBG Funding, [email protected]

SOURCE SBG Funding

NASHVILLE, Tenn., October 15, 2026 — Relevance Ventures (“Relevance”), one of the only independently owned Native American venture capital firms in the United States, today announced the expansion of its platform under the Relevance Capital brand to support established companies through a funded independent sponsor model. James Carey, a veteran private equity investor, joins as Managing Partner of Relevance Capital.

“Our venture strategy remains unchanged, but James gives us the experience and relationships to capitalize on lower-middle-market opportunities using an independent sponsor model,” said Cameron Newton, Managing Partner of Relevance Ventures. “We’ve listened carefully to the market and to our LPs, and this is a natural evolution of the Relevance platform. At the same time, the independent sponsor structure gives our investors greater choice through select co-investments in businesses with established revenue, profitability, and operating histories.”

Relevance Capital will pursue a new growth equity strategy focused on more established, profitable health companies operating within the broader Relevance platform. Carey will lead its investment activity, targeting companies that typically generate approximately $1 million to $15 million of EBITDA with established operations and clear opportunities for continued growth, extending Relevance’s reach later into the growth journey, while Relevance Ventures continues its existing venture focus on companies generating $1 million to $10 million in revenue with scalable solutions, large TAMs, and clear paths to profitability.

Relevance Capital will benefit from a differentiated competitive advantage through its ability to pursue new investments with a portion of the equity capital already committed through the broader Relevance network, providing greater transaction certainty, execution speed, and flexibility. Relevance Capital will identify and underwrite individual transactions and assemble additional capital around select opportunities. The approach complements Relevance’s traditional fund investing, giving its investor network access to later-stage co-investment opportunities on a deal-by-deal basis, offering more discretion to choose which opportunities to join and cultivated with the discipline of a firm that has deliberately stayed small.

“The lower middle market has always been compelling to me because you are working with real businesses at meaningful inflection points,” said Carey. “These companies have established customers, revenue, and profitability, but often reach a point where the right capital partner can help accelerate growth, pursue acquisitions or enter the next phase of the business. Relevance Capital gives us the flexibility to find those companies first and build the right investment structure around each opportunity.”

“This is an extension of something we have been doing naturally for years,” said Dean Newton, Chairman and General Partner of Relevance Ventures. “James allows us to institutionalize our capabilities and take it into the broader lower middle market. What is particularly interesting is combining an established venture platform and LP network with the flexibility of the independent sponsor model. We think that is a differentiated place to operate and a unique value proposition.”

Carey joins Relevance from Next Sparc Growth Partners, the single-family office of entrepreneur Len Pagon, where he served as Partner and Head of M&A. He brings more than 20 years of private markets experience across private equity, growth investing, and transaction sourcing and execution, including significant time at global private equity firm H.I.G. Capital, along with deep relationships across the lower-middle-market private equity and intermediary communities.

“South Florida has become a very different investment market over the last five years,” Carey added. “Miami is now the leading market in America for private capital, with private equity firms, family offices, hedge funds, entrepreneurs and operating companies continuing to build a presence here. I’ve spent my professional career in this market, and I’m excited to firmly cement Relevance into that ecosystem while executing Relevance Capital’s strategy on a national basis.”

Carey will be based in South Florida, where Relevance also plans to establish a physical presence in Miami, further extending its geographic growth beyond Nashville, Charlotte, and Denver. Carey has lived and worked in South Florida for more than two decades and brings extensive relationships across the region’s private equity, investment banking, professional services, and business communities.

About Relevance Ventures
Relevance Ventures is a Native American, privately owned and operated venture capital firm with more than $100 million under management. The firm invests in high-growth companies across personal health, community health, digital health, and financial health. Founded by Cameron and Dean Newton, Relevance is headquartered in Nashville, Tennessee, with an expanding presence in multiple U.S. growth markets. The Newtons are members of the Patawomeck Tribe of Virginia.

For more information, visit www.Relevanceventures.com.

SOURCE Relevance Ventures

Martinez Cohen will lead a shared technology team serving every ORANGE JUICE company; the company also reports more than 150 acquisition opportunities since its July launch.

WESTPORT, Conn., Oct. 15, 2026 — ORANGE JUICE (www.orangejuice.com), a permanent capital company backed by a Bitcoin treasury, today announced that Elias Martinez Cohen has joined the company as Chief Technology Officer. Martinez Cohen will build and lead a central technology team to serve every business ORANGE JUICE acquires, giving small and mid-sized companies engineering and AI capabilities typically accessible only to the largest enterprises.

For nearly eight years, Martinez Cohen served as a staff-level Senior System Software Engineer at NVIDIA, where he built the data pipelines and workflow platforms behind its self-driving program. He led the program’s AI storage platform team, helped double the capacity of its AI work queues and reduced the time required for data ingestion by an order of magnitude.

Martinez Cohen has worked in AI since 2013, when he joined Madbits, a deep-learning startup co-founded by Clément Farabet, now VP of Research at Google DeepMind. Twitter acquired Madbits in 2014 to form Twitter Cortex, its AI group, where Martinez Cohen helped build Twitter’s core machine-learning platform alongside a small, dedicated team. Former colleagues now build AI systems at Google DeepMind, OpenAI, and Anthropic.

“What’s technically possible today is far ahead of what most businesses actually use, and that gap keeps widening,” said Martinez Cohen. “A holding company can close it, because one technical team can serve many businesses and every win makes the next one cheaper. We’re not here to automate away people. We’re going after the drudgery.”

“Owners shouldn’t have to navigate the AI transition alone,” said Ruben Zweiban, operating partner of ORANGE JUICE. “Founders who join us gain Elias’ capability and expertise on day one, without giving up the identity of the business they built.”

Because ORANGE JUICE buys businesses with strong existing economics and never needs to sell them, it treats technology as upside and can invest in it for the long term.

Martinez Cohen’s essay, “Why I Left NVIDIA for ORANGE JUICE,” is available here.

Continued Momentum Since Launch

ORANGE JUICE launched in July 2026 after closing a Series A funding round of more than $40 million from investors including anchor investor Ricardo Salinas, founder and chairman of Grupo Salinas, and Tim Reynolds. The company was founded by ego death capital partners Jeff Booth, Lyn Alden, Nico Lechuga, and Andi Pitt, along with Adrian Steckel and Ruben Zweiban. Since the close, the company has received tens of millions of dollars in additional unsolicited investor interest, reflecting continued demand for the ORANGE JUICE model.

ORANGE JUICE has received more than 150 acquisition opportunities since launch. These opportunities span essential business services, healthcare services, and manufacturing, with adjusted EBITDA generally ranging from approximately $2 million to more than $15 million. The majority of qualified opportunities have originated organically through ORANGE JUICE’s inbound network, confirming growing interest in its alternative permanent-capital model.

Business owners can learn more at orangejuice.com or contact [email protected].

Follow ORANGE JUICE on X: @orangejuice_btc.

About ORANGE JUICE: ORANGE JUICE HODLINGS Inc. (www.orangejuice.com) (“ORANGE JUICE”) acquires, improves, and permanently holds cash-flow-generating businesses, backed by a Bitcoin treasury. Founded in 2026, ORANGE JUICE is headquartered in Connecticut, USA.

Media Inquiries: [email protected]

SOURCE ORANGE JUICE

New hires deepen the firm’s institutional relationships and capital markets capabilities and offerings

NEW YORK, Oct. 15, 2026 — Yorkville Ives & Co., LLC (“Yorkville Ives”), a full-service investment bank providing financial advisory, capital raising and proprietary equity research, today announced six senior hires across its institutional sales, trading and capital markets sectors. The appointments mark another step in the firm’s expansion following its formation in April 2025.

The new hires include Zach Goldan, Managing Director, Head of New York Institutional Sales; Owen O’Neil, Head of Boston Institutional Sales; Kevin Reynolds, Managing Director and Head of Capital Markets; Matt Stedman, Managing Director and Head of Debt Capital Markets; Scott Ammaturo, Senior Managing Director and Head of ATM Trading; and Keith Pompliano, Senior Managing Director. Together, they bring decades of Wall Street experience, established institutional relationships and expertise across key areas of the firm’s business.

“When we announced the rebranding to Yorkville Ives in July, we had a clear vision of what we wanted to build. Now, we’re putting the team in place to make that vision a reality,” said Dan Ives, Partner and Senior Managing Director of Yorkville Ives. “We’ve brought together experienced professionals across investment banking, sales, trading and research, giving us the deep bench strength to keep building on that foundation. It’s an exciting time for the firm, and these additions are a big part of where we’re headed.”

Zach Goldan joins Yorkville Ives as Managing Director, Head of New York Institutional Sales, bringing 15 years of experience at Stifel, where he served as Managing Director in institutional equity sales and covered clients across the New York and Mid-Atlantic markets. He began his career as an analyst at Westwicke Partners and has been a CFA charterholder since 2011.

Owen O’Neil joins as Head of Boston Institutional Sales, bringing more than 30 years of experience in institutional sales. He previously held senior positions at Rosenblatt Securities, Maxim Group, D.A. Davidson, Brean Capital, Susquehanna Investment Group and Pacific Crest Securities. Prior to his Wall Street career, O’Neil served as a Naval Aviator for 10 years.

“Owen and Zach provide our franchise with credible, seasoned sales perspectives, and deep relationships across leading buyside accounts, with particular strength in the Boston and New York markets,” said Kevin Merritt, Director of Research at Yorkville Ives.

Yorkville Ives is also expanding its credit and capital markets capabilities, with additional senior appointments spanning leveraged finance and ATM trading.

Kevin Reynolds joins as Managing Director, Head of Capital Markets, bringing extensive experience in debt financing and capital markets origination. Previously, he led debt capital markets at Cantor Fitzgerald and served as Global Head of Debt and Equity Capital Markets at Cowen and Co. Earlier in his career, he was Global Head of Asset-Backed Securitizations, Liability Management and Emerging Market Debt Capital Markets at UBS.

Matt Stedman joins as Managing Director, Head of Debt Capital Markets, bringing experience in leveraged finance and institutional credit sales and trading. Most recently, he worked at Seaport Global, where he focused on distressed debt, high-yield securities and alternative assets. Previously, he led sales, trading and capital markets syndication activities at Morgan Joseph. Matt began his career at Drexel Burnham and was a senior member of their high yield department.

Scott Ammaturo joins as Senior Managing Director, Head of ATM Trading, bringing decades of Wall Street experience in equity trading and at-the-market (ATM) offerings. He previously served as Senior Managing Director and Head of ATM Trading at B. Riley Securities, where he oversaw ATM trading operations. His career spans senior trading roles at several Wall Street firms, including MLV & Co., Merrill Lynch and Morgan Stanley.

Keith Pompliano joins as Senior Managing Director, bringing decades of Wall Street experience in capital markets trading and at-the-market (ATM) offerings. He previously held senior positions at B. Riley Securities and FBR, focusing on capital markets trading and ATM programs. Earlier in his career, he held institutional sales and trading roles at MLV & Co. and UNX. Pompliano and Ammaturo have worked together for nearly 20 years, executing close to 1,000 ATM offerings and building a longstanding partnership grounded in client service and execution expertise.

“We are committed to building the ‘best in breed’ investment bank, totally focused on the AI revolution and the sectors supporting its development. We plan to accomplish this objective by providing superior equity research, sales and trading to both our issuer clients and institutional buyers. Our new team will be critical assets in helping us achieve this goal,” said Roger Briggs, Chief Executive Officer at Yorkville Ives.

About Yorkville Ives & Co., LLC
Yorkville Ives & Co., LLC (“Yorkville Ives”) is a full-service investment bank and registered broker-dealer. Headquartered in New Jersey and affiliated with Yorkville Advisors Global, L.P., an SEC-registered investment adviser to a family of investment funds, Yorkville Ives provides financial advisory, capital raising, and U.S. execution and distribution services to companies across public and private markets. Its focus spans AI and disruptive technology, enterprise software, defense technology, industrials, energy, power and infrastructure, and other growth sectors. Yorkville Ives platform also includes an equity research department focused on technology and other growth sectors. Yorkville Ives is a member of FINRA and SIPC.

SOURCE Yorkville Ives & Co.

HOUSTON, Oct. 15, 2026 — Specialty1 Partners (S1P), the leading doctor-founded, doctor-led specialty dental partnership organization, is embracing the future of healthcare through strategic investments in artificial intelligence (AI) technologies designed to enhance patient care, improve operational efficiency and support the continued growth of its national network of specialty dental practices.

With more than 225 practices across 29 states, Specialty1 Partners is taking a proactive approach to identifying and adopting emerging technologies that have the potential to transform how specialty dental practices operate.

Throughout 2026, the organization has conducted a comprehensive evaluation of AI-powered tools and platforms, focusing on solutions that address real-world challenges faced by clinicians, patients and practice teams. The result is a growing technology initiative that brings AI into several key areas of the organization, from clinical documentation and patient communications to administrative workflows and business operations.

“At Specialty1 Partners, we believe the future of specialty dentistry will be shaped by organizations willing to embrace innovation while staying focused on what matters most, the patient,” said Dr. Daryl Dudum, Co-Chief Executive Officer of Specialty1 Partners. “Artificial intelligence has tremendous potential to change how we deliver care and manage our practices. We’re investing in that future today, ensuring our doctors and teams have access to technologies that can help them work smarter, operate more efficiently and spend more time focused on their patients.”

Bringing Artificial Intelligence Into Everyday Practice Operations

Specialty1 Partners’ AI strategy focuses on practical applications designed to address some of the most common challenges facing specialty dental practices.

Key areas of investment include:

• Clinical Documentation and Physician Efficiency: AI-powered clinical documentation tools designed to simplify the creation of patient notes, referral communications and other clinical documents, reducing administrative demands on clinicians.
• Patient Access and Communication: Intelligent communication technologies that help manage incoming calls, respond to patient inquiries, support appointment scheduling and improve the overall patient experience.
• Insurance and Administrative Automation: AI-enabled solutions designed to streamline insurance verification, benefits inquiries, prior authorizations and other time-consuming administrative processes.
• Business Operations and Contract Management: Advanced technologies that assist with document management, contract workflows and administrative processes, improving consistency and efficiency across the organization.
• Workplace Productivity and Collaboration: AI-powered tools that support information sharing, meeting summaries, reporting, communications and other everyday business functions, helping teams work more effectively.

These investments reflect a broader commitment to using technology to simplify complexity, improve practice operations and strengthen the support available to S1P’s clinicians and their teams.

Innovation That Supports Doctors and Staff, Not Replaces Them

As a doctor-led organization, Specialty1 Partners recognizes that technology is most valuable when it enhances the expertise of clinicians and strengthens the personal relationships at the heart of patient care.

Rather than viewing AI as a replacement for people, S1P sees it as an opportunity to reduce repetitive administrative work, improve access to information and give clinicians and team members more time to focus on higher-value activities.

“Our goal has always been to provide our partner practices with the resources and infrastructure they need to be successful while allowing doctors to maintain their clinical independence,” said Dr. Matthew Haddad, Co-Chief Executive Officer of Specialty1 Partners. “AI is a natural extension of that commitment. By investing in innovative technologies and incorporating them into our support platform, we’re creating opportunities to strengthen practice performance, improve the patient experience and build a more scalable organization for the future.”

The initiative also reflects Specialty1 Partners’ belief that technology will play an increasingly important role in addressing some of healthcare’s most persistent challenges, including growing administrative demands, staffing pressures and the need to deliver consistently exceptional patient experiences.

A Long-Term Commitment to Innovation

Specialty1 Partners views its current AI investments as the beginning of a longer-term strategy rather than a one-time technology initiative.

Following its evaluation and selection efforts in 2026, the organization is focused on implementation, adoption and identifying opportunities to expand the use of AI across its network.

Beginning in the first quarter of 2027, S1P expects to assess initial performance indicators related to operational efficiency, patient access, administrative productivity and practice performance. These findings will help inform future investments and opportunities to scale successful applications.

“We’re approaching AI with both enthusiasm and discipline,” added Dr. Dudum. “It’s not about adopting technology simply because it’s new. It’s about identifying solutions that solve meaningful problems and create lasting value. We see tremendous opportunity ahead, and we’re committed to ensuring Specialty1 Partners and our doctors are well positioned for the next generation of specialty dental care.”

Through continued investments in technology, people and operational infrastructure, Specialty1 Partners is reinforcing its position as a forward-thinking specialty dental organization committed to helping its partner practices succeed in a rapidly evolving healthcare landscape.

About Specialty1 Partners

Specialty1 Partners is the leading specialty partnership organization for dental specialty practices, offering comprehensive services in billing, HR, IT, business analytics, procurement, credentialing, marketing, training, compliance, and more.

Founded by doctors, the company combines clinical insight with deep operational expertise to help practices thrive while preserving clinical autonomy.

Headquartered in Houston, TX, Specialty1 Partners supports over 225 practices across 29 states and more than 350 specialists nationwide. The organization has been recognized on the Inc. 5000 list for six consecutive years, ranking among the fastest-growing private companies in America.

Better Care. Better Business. Better Oral Health.

Media Contact:
Lyle Rountree
Specialty1 Partners
1800 West Loop S., Suite 2000
Houston, TX 77027
Phone: 800-605-3437 | Email: [email protected]
www.specialty1partners.com

SOURCE Specialty 1 Partners

• Requests and purchase orders: Employees raise requests against the live budget, so budget owners see the financial impact before anything is approved, committed or invoiced.
• Contracts and invoices: Contracts, subscriptions and agreements live in one place. Invoices are captured, coded and matched to purchase orders and contracts automatically, and any discrepancies or unexpected charges are flagged for review.
• Cards and payments: Finance can now issue Datarails physical and virtual corporate cards with configurable controls and auto-coded transactions. Approved bills are scheduled for payment before any money goes out.
• Reconciliation and AI: Spend records reconcile against the ERP. AI handles invoice extraction, coding, transaction classification, matching and discrepancy detection.

“Most spend platforms kick in when an employee wants to buy something,” said Didi Gurfinkel, Co-founder and CEO of Datarails. “Datarails Spend starts earlier, with the plan. Before a request is approved, finance can check it against live budgets and see what’s left to spend. Once approved, the commitment stays tied to the budget through every step: purchase orders, contracts, invoices, payments and reconciliation. Actual spend flows back to the line it was approved against, so finance always knows what’s been spent, what’s committed and what’s still available.”

Built on FinanceOS – Datarails’ governed financial data foundation for planning, budgeting, forecasting, reporting, cash management and close – Datarails Spend brings spend activity into the same system used across finance. This enables teams to understand spending decisions without piecing together data from disconnected systems.

“The goal is not to automate decisions about where a company’s money goes, but to eliminate the manual work around those decisions. That is where AI can make a real difference in the spend process,” Gurfinkel said. “The result is a shift from reactive spend management to proactive financial control for all companies.”

Datarails Spend is available now: datarails.com/products/spend

About Datarails

Datarails is the AI finance operating system, bringing together FP&A, spend, cash management, ticketing, and month-end close on one unified platform. FinanceOS is the trusted data layer for finance teams, connecting financial and operational data into a governed foundation so every AI workflow and output is accurate, consistent, and auditable. Whether working in Excel, Google Sheets, or a web-based platform, finance teams can automate the work, trust the numbers, and turn the Office of the CFO into a strategic driver of the business.

Media Contact
[email protected]

SOURCE Datarails